{{Rsnum
|rsid=4802101
|Gene=CYP2B6
|Chromosome=19
|position=40990556
|Orientation=plus
|GMAF=0.2966
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CYP2B6
}}{{PharmGKB
|RSID=rs4802101
|Name_s=CYP2B6: -750T>C
|Gene_s=CYP2B6, CYP2A7P1
|Feature=Intron, Intron
|Evidence=PubMed ID:17638512
|Annotation=This SNP is part of many CYP2B6 haplotypes (*1G; *1H, *1J, *1K, *1L, *1N, *4B, *5B, *6B, *6C, *7B, *22). -750T>C is situated in the promoter region and predicted to disrupt an HNF1alpha stite. In human liver expression studies individuals with one or two -750C alleles had 1.4-fold and 1.8-fold less CYP2B6 CYP2B6 protein.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA162355667
}}{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4802101
|overall_frequency_n=97
|overall_frequency_d=128
|overall_frequency=0.757812
|n_genomes=51
|n_genomes_annotated=0
|n_haplomes=84
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}